Nautilus Biotechnology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $350.1M
Liabilities Breakdown FY2022
Total Liabilities: $35.1M
Asset Breakdown
Total Assets: $350.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $114.5M | 32.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.7M | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $231.8M | 66.2% |
Liabilities Breakdown
Total Liabilities: $35.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.3M | 3.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $33.9M | 96.4% |